These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 21525481)
1. Comparative efficiency and safety of pharmacological approaches to the management of obesity. Hainer V Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S349-54. PubMed ID: 21525481 [No Abstract] [Full Text] [Related]
2. [Anti-obesity drugs: sibutramine and orlistat]. Sempere I Verdú E; Palop Larrea V; Hidalgo Mora JJ; Martínez-Mir I Med Clin (Barc); 2002 Mar; 118(11):437; author reply 437-8. PubMed ID: 11943108 [No Abstract] [Full Text] [Related]
3. Currently available drugs for the treatment of obesity: Sibutramine and orlistat. Chaput JP; St-Pierre S; Tremblay A Mini Rev Med Chem; 2007 Jan; 7(1):3-10. PubMed ID: 17266632 [TBL] [Abstract][Full Text] [Related]
5. [Drugs for obesity. Why are obese patients diferent?]. García-Luna PP; Soto Moreno AM Med Clin (Barc); 2001 Nov; 117(14):539-40. PubMed ID: 11707221 [No Abstract] [Full Text] [Related]
6. New pharmacological directions for the treatment of overweight and obesity. Van Gaal LF; Peiffer FW; De Leeuw IH Acta Clin Belg; 1999 Jun; 54(3):141-6. PubMed ID: 10443041 [No Abstract] [Full Text] [Related]
7. Is new hope on the horizon for obesity? Bray GA Lancet; 2008 Nov; 372(9653):1859-1860. PubMed ID: 19041787 [No Abstract] [Full Text] [Related]
8. Medical management of obesity: a clinical imperative? Haynes WG Curr Diab Rep; 2003 Feb; 3(1):1-3. PubMed ID: 12643140 [No Abstract] [Full Text] [Related]
9. [The pharmacological treatment of obesity: past, present and future]. Simonyi G; Pados G; Medvegy M; Bedros JR Orv Hetil; 2012 Mar; 153(10):363-73. PubMed ID: 22370224 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacotherapy in the treatment of obesity]. Hamann A MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392 [TBL] [Abstract][Full Text] [Related]
12. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions. Coutinho W Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219 [TBL] [Abstract][Full Text] [Related]
14. Prevention and management of obesity: pharmacology . Finer N Proc Nutr Soc; 2000 Aug; 59(3):413. PubMed ID: 10997657 [No Abstract] [Full Text] [Related]
15. [New treatments for obesity]. Féry F; Watrin I Rev Med Brux; 1999 Sep; 20(4):A381-5. PubMed ID: 10523928 [TBL] [Abstract][Full Text] [Related]
16. Orlistat for obesity. Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767 [No Abstract] [Full Text] [Related]
17. Long-term pharmacotherapy for obesity and overweight. Padwal R; Li SK; Lau DC Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004 [TBL] [Abstract][Full Text] [Related]
18. Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance. Gursoy A; Erdogan MF; Cin MO; Cesur M; Baskal N Eat Weight Disord; 2006 Dec; 11(4):e127-32. PubMed ID: 17272944 [TBL] [Abstract][Full Text] [Related]
19. Medical management of obesity: present and future therapy. Klein S J Gastrointest Surg; 2003; 7(4):464-467. PubMed ID: 12763399 [No Abstract] [Full Text] [Related]
20. Obesity and pharmacologic therapy. Thearle M; Aronne LJ Endocrinol Metab Clin North Am; 2003 Dec; 32(4):1005-24. PubMed ID: 14711072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]